Pharmaceutical
FDA MedWatch Drug Alerts
- Audience: Consumer May 15, 2026 — As is standard practice, the FDA is notifying consumers not to use expired Amazon Basic Care Levonorgestrel 1.5 mg. The FDA is aware several lots of this product were delivered to purchasers past the labeled…
- Audience: Health Care Professional MUMBAI, INDIA and PRINCETON, NJ – May 13, 2026 – Sun Pharma is voluntarily recalling within the U.S. to the hospital/user level, one batch of DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL, Lot #…
- Audience: Consumer May 12, 2026 — Pharmacal is recalling one lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube to the consumer level. The product has been found to be contaminated with Staphylococcus…
- Audience: Health Care Providers, Patients The U.S. Food and Drug Administration (FDA) is alerting patients and health care providers about the voluntary withdrawal of Tazverik (tazemetostat) tablets from the market due to an increased rate of…
- Audience: Consumer May 11, 2026 — XD Investments LLC of Houston, TX, is voluntarily recalling approximately 448 Boxes of Better Weather Fix Elixir products, including all flavors and variations, because FDA analysis found the products to contain…
New Drug Approvals
- OSAKA, Japan, June 1, 2026 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced that the U.S. Food and Drug Administration (FDA) has approved Xocova…
- MUMBAI & SHORT HILLS, NEW JERSEY May 30, 2026 – Wockhardt today announced that the U.S. Food and Drug Administration (FDA) has approved Zaynich (cefepime and zidebactam), a novel intravenous antibiotic for the treatment of adults with…
- DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 29, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for…
- May 28, 2026 — AstraZeneca’s Imfinzi (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve, high-risk…
- HORSHAM, PA – (May 28, 2026) – Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to include evidence in the Tremfya…
New Drug Applications
- BOSTON–(BUSINESS WIRE)–Jun. 1, 2026– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) submission for povetacicept, an…
- South San Francisco, CA — June 1, 2026 — Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the United States (U.S.) Food and Drug Administration (FDA) has accepted the company’s New Drug Application…
- WALTHAM, Mass., May 28, 2026 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in…
- PENNINGTON, N.J. and AHMEDABAD, India, May 28, 2026 /PRNewswire/ — Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Limited, a global innovation-led health care company, today announced that the US Food and Drug Administration…
- WALTHAM, Mass. and BOULDER, Colo., May 28, 2026 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that the U.S. Food and…
Clinical Trial Results
- June 2, 2026 — Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a cyclin-dependent kinase (CDK) 4/6 inhibitor – palbociclib, ribociclib or abemaciclib – maintained its…
- REDMOND, Wash. & PRINCETON, N.J.– June 2, 2026 — (BUSINESS WIRE)– SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today announced that SystImmune’s parent company, Sichuan…
- CAMBRIDGE, MA and RAHWAY, N.J. / Access Newswire / June 1, 2026 / Moderna, Inc. (NASDAQ: MRNA) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced detailed results from a planned five-year follow-up analysis…
- June 1, 2026 — The National Institutes of Health (NIH) today announced that its Investigational New Drug (IND) application for mitragynine, the primary psychoactive compound found in Mitragyna speciosa (kratom), has taken effect with the U.S. Food…
- BRUSSELS, Belgium and CAMBRIDGE, Mass. — June 1, 2026, 07:00 (CEST) — UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced that The Lancet, a world-leading medical journal, has published the full results from…
Daily Med News
- FRIDAY, June 5, 2026 — This is not science fiction or some perverse prank. A Silicon Valley tech giant is seeking federal approval to release up to 64 million sterilized male mosquitoes in California and Florida over the next two years. The…
- FRIDAY, June 5, 2026 — A suburban Chicago woman who feared she might never have another child is now celebrating a growing family after brain surgery at Northwestern Medicine. After the birth of her first daughter in 2022, Lisa Fasone began…
- FRIDAY, June 5, 2026 — A common class of blood pressure medications might contribute to kidney damage among people with type 2 diabetes, a new study says. Dihydropyridine calcium-channel blockers (DCCBs) work by relaxing blood vessels, and…
- FRIDAY, June 5, 2026 — In the old days, expecting mothers were encouraged to take it easy as much as possible. But that advice had it completely backward, a new study says. There are higher odds of pregnancy complications for women who spend…
- FRIDAY, June 5, 2026 — Electrical stimulation of the spinal cord might improve arm function among people who’ve suffered a stroke, pilot clinical trial results say. Seven stroke survivors with profound muscle weakness had an average 32%…
News for Health Professionals
- FRIDAY, June 5, 2026 — A five-minute session of proximal intercessory prayer (PIP) significantly reduces pain and anxiety in primary care patients, according to a study published in the May/June issue of the Annals of Family Medicine.Katherine…
- FRIDAY, June 5, 2026 — About 16 percent of COVID-19 cases develop postacute sequelae of severe acute respiratory syndrome coronavirus-2 infection (PASC), according to a study published online May 27 in JAMA Network Open.Jiazi Tian, from…
- FRIDAY, June 5, 2026 — A higher polygenic risk score (PRS) for pulse pressure is associated with an increased risk for dementia as a contributing cause of death (DCCD), according to a study published online June 3 in Neurology. Daeeun Kim, Ph.D…
- FRIDAY, June 5, 2026 — Perioperative treatment with apalutamide and androgen deprivation therapy (ADT) is beneficial for patients with high-risk localized or locally advanced prostate cancer, according to a study published online June 2 in the New…
- FRIDAY, June 5, 2026 — For patients with psoriasis with stable low disease activity, dose reduction (DR) through stepwise interval prolongation of interleukin (IL)-17 and 23 inhibitors (i) is effective and safe, according to a study published…
